Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Bergmann

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 24, 2021
Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failureNikola Kozhuharov, Leong Ng, Desiree Wussler, et al.
Journal of the American College of Cardiology|January 7, 2017
Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network StudyLeong L Ng, Iain B Squire, Donald J L Jones, et al.
Journal of Intensive Care|April 2, 2016
Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failureAlexandre Mebazaa, Pierre François Laterre, James A Russell, et al.
Bioorganic & Medicinal Chemistry|June 6, 2021
Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistryJohn P Guilinger, Archna Archna, Martin Augustin, et al.
Kidney International Reports|November 20, 2018
Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) StudyAlexa Hollinger, Xavier Wittebole, Bruno François, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
European Journal of Heart Failure|February 4, 2012
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Sean-Xavier Neath, Judd Landsberg, et al.
Critical Care (London, England)|December 26, 2018
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) studyAlexandre Mebazaa, Christopher Geven, Alexa Hollinger, et al.
Circulation. Heart Failure|July 19, 2011
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) studyAlan Maisel, Yang Xue, Kevin Shah, et al.
Journal of the American College of Cardiology|May 8, 2010
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Christian Mueller, Richard Nowak, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 24, 2021
Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failureNikola Kozhuharov, Leong Ng, Desiree Wussler, et al.
Journal of the American College of Cardiology|January 7, 2017
Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network StudyLeong L Ng, Iain B Squire, Donald J L Jones, et al.
Journal of Intensive Care|April 2, 2016
Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failureAlexandre Mebazaa, Pierre François Laterre, James A Russell, et al.
Bioorganic & Medicinal Chemistry|June 6, 2021
Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistryJohn P Guilinger, Archna Archna, Martin Augustin, et al.
Kidney International Reports|November 20, 2018
Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) StudyAlexa Hollinger, Xavier Wittebole, Bruno François, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
European Journal of Heart Failure|February 4, 2012
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Sean-Xavier Neath, Judd Landsberg, et al.
Critical Care (London, England)|December 26, 2018
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) studyAlexandre Mebazaa, Christopher Geven, Alexa Hollinger, et al.
Circulation. Heart Failure|July 19, 2011
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) studyAlan Maisel, Yang Xue, Kevin Shah, et al.
Journal of the American College of Cardiology|May 8, 2010
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Christian Mueller, Richard Nowak, et al.
Pageof 26